| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/25/2004 | WO2004024762A2 Il-8 like protein |
| 03/25/2004 | WO2004024761A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/25/2004 | WO2004024760A1 Novel protein and dna thereof |
| 03/25/2004 | WO2004024756A2 Orthopoxvirus antigens and use thereof |
| 03/25/2004 | WO2004024749A2 Thermostable reverse transcriptases and uses thereof |
| 03/25/2004 | WO2004024744A2 Production of glycosylated macrolides in e. coli |
| 03/25/2004 | WO2004024283A2 Apparatus and method for preparative scale purification of nucleic acids |
| 03/25/2004 | WO2004024227A2 Systems of sperm cell preservation and processing |
| 03/25/2004 | WO2004024190A2 Recombinant lentivirale vector pseudotyped with the hemagglutinin protein for gene transfer into the retina |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | WO2004024079A2 Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024069A2 Novel compositions and methods for the treatment of immune-related diseases |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004023870A1 Human slt transgenic animal |
| 03/25/2004 | WO2004023869A1 Use of plag or plag-inhibitors to diagnose and/or treat disease |
| 03/25/2004 | WO2004023867A2 Transgenic cancer models in fish |
| 03/25/2004 | WO2004016811A3 Methods and kit for genes shuffling using tagged primers |
| 03/25/2004 | WO2004016777A3 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 03/25/2004 | WO2004016760A9 Novel variant hyprocrea jecorina cbh1 cellulases |
| 03/25/2004 | WO2004016274A3 Novel peptide-conjugated oligomeric compounds |
| 03/25/2004 | WO2004013319A3 Regulation of human esterase |
| 03/25/2004 | WO2004013070A3 Multi-step synthesis of templated molecules |
| 03/25/2004 | WO2004009819A3 Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor |
| 03/25/2004 | WO2004009624A3 Three finger toxin fold protein |
| 03/25/2004 | WO2004009621A3 Polypeptides of nontypeable haemophilus influenzae |
| 03/25/2004 | WO2004007722A3 Transgenic animal expressing alzheimer’s tau protein |
| 03/25/2004 | WO2004007718A3 Rna-interference by single-stranded rna molecules |
| 03/25/2004 | WO2004007670A3 RECOMBINANT TYPE II RESTRICTION ENDONUCLEASES, MmeI AND RELATED ENDONUCLEASES AND METHODS FOR PRODUCTING THE SAME |
| 03/25/2004 | WO2004007660A3 Novel hsf transcription factors and use thereof in transgenic plants |
| 03/25/2004 | WO2004006667A3 Methods for the regeneration and transformation of cotton |
| 03/25/2004 | WO2004005346A8 Human nuclear hormone receptor |
| 03/25/2004 | WO2004003135A3 Selective cloning of homoduplex nucleic acids |
| 03/25/2004 | WO2004000011A3 Methods for developing animal models |
| 03/25/2004 | WO2003102174A3 Modified phytases |
| 03/25/2004 | WO2003100059A3 Molecular targeting of the igf-1 receptor |
| 03/25/2004 | WO2003100001A3 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/25/2004 | WO2003097677A3 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003093430A3 Methods and compositions for use in preparing sirnas |
| 03/25/2004 | WO2003093424A3 In vivo ssdna expression vectors for altering gene expression |
| 03/25/2004 | WO2003091401A3 Multi plasmid system for the production of influenza virus |
| 03/25/2004 | WO2003088996A3 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 03/25/2004 | WO2003088911A3 Universal libraries for immunoglobulins |
| 03/25/2004 | WO2003087330A3 Vac-bac shuttle vector system |
| 03/25/2004 | WO2003083481A3 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies |
| 03/25/2004 | WO2003083098A3 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 03/25/2004 | WO2003083051A3 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples |
| 03/25/2004 | WO2003081993A3 Transgenic aves producing human polyclonal antibodies |
| 03/25/2004 | WO2003081992A3 The functional disruption of avian immunoglobulin genes |
| 03/25/2004 | WO2003081988A3 Generation of plants with improved drought tolerance |
| 03/25/2004 | WO2003077844A3 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 03/25/2004 | WO2003076591A3 Compositions and methods for generating an immune response |
| 03/25/2004 | WO2003076472A3 Neoplasm specific antibodies and uses thereof |
| 03/25/2004 | WO2003075747A3 Contrast agents for magnetic resonance imaging and methods related thereto |
| 03/25/2004 | WO2003074655A3 Regulated vectors for controlling dna hypermutability in eukariotic cells |
| 03/25/2004 | WO2003074553A3 Expec-specific proteins, genes encoding them and uses thereof |
| 03/25/2004 | WO2003074546A3 Streptavidin-binding peptide |
| 03/25/2004 | WO2003072804A3 Nanostructures containing pilin protein |
| 03/25/2004 | WO2003070884A3 RNA INTERFERENCE MEDIATED INHIBITION OF MDR P-GLYCOPROTEIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/25/2004 | WO2003070875B1 Container with at least one electrode |
| 03/25/2004 | WO2003070735A3 Components for producing amphoteric liposomes |
| 03/25/2004 | WO2003068978A3 Combinations of vectors and the hosts thereof for the propagation and expression of recombinant genes without recourse to antibiotics |
| 03/25/2004 | WO2003068944A3 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α- |
| 03/25/2004 | WO2003068712A3 Novel method for production of dna biochips and applications thereof |
| 03/25/2004 | WO2003066857A3 Elements for modulating plant dna replication, transformation rate, cell cycle regulation and growth |
| 03/25/2004 | WO2003060079A3 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |
| 03/25/2004 | WO2003059374A3 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 03/25/2004 | WO2003057910A3 Use of silica material in an amplification reaction |
| 03/25/2004 | WO2003057823A3 Epitope synchronization in antigen presenting cells |
| 03/25/2004 | WO2003056340A3 Fadd proteins, phosphorylated p38-mapk and fasl as tumour markers |
| 03/25/2004 | WO2003056023A8 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 03/25/2004 | WO2003055443A3 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003052134A3 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor |
| 03/25/2004 | WO2003035828A3 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003033659A3 Antisense modulation of matrix metalloproteinase 1 expression |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003031472A3 Insulin mimetic amino acid sequences |
| 03/25/2004 | WO2003020887A3 Gene identification |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003014745A3 Method for identifying anti-inflammatory drugs |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003010186A3 Method for making acylated polypeptides |
| 03/25/2004 | WO2003010185A3 Method for making acylated polypeptides |
| 03/25/2004 | WO2003006501A3 G-csf conjugates |
| 03/25/2004 | WO2003006103A3 Electrical field stimulation of eukaryotic cells |
| 03/25/2004 | WO2003000941A3 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 03/25/2004 | WO2002098455A3 Production of recombinant human arylsulfatase a |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002094855A3 Peptide synthesis method |
| 03/25/2004 | WO2002092780A3 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |